Glaukos Corp (GKOS) support and resistance · rev $383.5M
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
This page maps Glaukos Corp (GKOS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GKOS revenue for 2024-12-31 was $383.5M. Net income was -$146.4M. Revenue was up 21.9% from 2023-12-31 to 2024-12-31. GKOS currently screens at market cap $7.63B.
GKOS currently screens at market cap $7.63B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GKOS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GKOS quote page for the session range and the stock page for the full model.
Not investment advice.